This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2017 Oct 5;117(10):1840.

doi: 10.1160/TH17-08-0573. Epub 2017 Sep 1.

Accumulating data on rivaroxaban for venous thromboembolism in clinical practice

Affiliations

Affiliation

¹ Sam Schulman, MD, Thrombosis Service, HHS-General Hospital, 237 Barton Street East, Hamilton, ON, L8L 2X2, Canada, Tel.: +1 905 5270271, ext 44479, Fax: +1 905 5211551, E-mail: schulms@mcmaster.ca.

PMID: 28862285
DOI: 10.1160/TH17-08-0573

Editorial

Accumulating data on rivaroxaban for venous thromboembolism in clinical practice

Sam Schulman. Thromb Haemost. 2017.

. 2017 Oct 5;117(10):1840.

doi: 10.1160/TH17-08-0573. Epub 2017 Sep 1.

Author

Affiliation

¹ Sam Schulman, MD, Thrombosis Service, HHS-General Hospital, 237 Barton Street East, Hamilton, ON, L8L 2X2, Canada, Tel.: +1 905 5270271, ext 44479, Fax: +1 905 5211551, E-mail: schulms@mcmaster.ca.

PMID: 28862285
DOI: 10.1160/TH17-08-0573

No abstract available

PubMed Disclaimer

Comment on

Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI, Bunz TJ, Turpie AGG. Coleman CI, et al. Thromb Haemost. 2017 Oct 5;117(10):1841-1847. doi: 10.1160/TH17-03-0210. Epub 2017 Jun 22. Thromb Haemost. 2017. PMID: 28640322

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Georg Thieme Verlag Stuttgart, New York
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations